The comparative effects of bariatric surgery on weight and type 2 diabetes

Obesity Surgery

Volumn 17, Issue 9, 2007, Pages 1248-1256

  Levy, Pierre ^a   Fried, Martin ^b   Santini, Ferruccio ^c   Finer, Nick ^d  

^a UNIVERSITÉ PARIS DAUPHINE   (France)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Bariatric surgery; Literature review; Morbid obesity; Treatment outcome; Type 2 diabetes mellitus; Weight loss

Indexed keywords

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DIABETES CONTROL; GASTRIC BANDING; GASTROPLASTY; HUMAN; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; STOMACH BYPASS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION; COST; ECONOMICS; META ANALYSIS; MORBID OBESITY;

BARIATRIC SURGERY; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; HUMANS; META-ANALYSIS AS TOPIC; OBESITY, MORBID; WEIGHT LOSS;

EID: 38549114532     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9214-z     Document Type: Review

References (58)

1. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
2. Mokdad AH, Ford ES, Bowman BA et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23: 1278-83.
3. Gregg EW, Cadwell BL, Cheng YJ et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 2004; 27: 2806-12.
4. Fox CS, Pencina MJ, Meigs JB et al. Trends in the incidence of Type 2 diabetes mellitus from the 1970s to the 1990s: The Framingham Heart Study. Circulation 2006; 113: 2914-8.
5. International Diabetes Federation, Diabetes Atlas - Executive Summary, ed. I.D. Federation. 2003. http://www.eatlas.idf.org/webdata/docs/Atlas%202003- Summary.pdf
6. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care 2003; 26: 61-9.
7. Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. Also published on http://www.who.int/chp/chronic_disease_report/en.
8. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
9. Caterson ID, Hubbard V, Bray GA et al. Prevention Conference VII: Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Group III: Worldwide Comorbidities of Obesity. Circulation 2004; 110: e476-83.
10. Malnick SDH and Knobler H. The medical complications of obesity. QJM 2006; 99: 565-79.
11. Hartemink N, Boshuizen HC, Nagelkerke NJD et al. Combining risk estimates from observational studies with different exposure cutpoints: A meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 2006; 163: 1042-52.
12. Colditz GA, Willett WC, Rotnitzky A et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-6.
13. Chan JM, Rimm EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-9.
14. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-22.
15. Koh-Banerjee P, Wang Y, Hu FB et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US Men. Am J Epidemiol 2004; 159: 1150-9.
16. Hamman RF, Wing RR, Edelstein SL et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29: 2102-7.
17. Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: iii-iv, 1-182.
18. Lean ME, Powrie JK, Anderson AS et al. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990; 7: 228-33.
19. Rigby N, James P. The obesity campaign view of diabetes prevention. Diabetes Voice 2003; 48: 20-3.
20. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
21. Maggard MA, Shugarman LR, Suttorp M et al. Metaanalysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-59.
22. Shekelle PG, Morton SC, Maglione M et al. Pharmacological and surgical treatment of obesity. Evid Rep Technol Assess (Summ) 2004: 1-6.
23. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613-24.
24. Hall JC, Watts JM, O'Brien PE et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg 1990; 211: 419-27.
25. Nilsell K, Thorne A, Sjostedt S et al. Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001; 167: 504-9.
26. Morino M, Toppino M, Bonnet G et al. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 2003; 238: 835-41; discussion 841-2.
27. Westling A, Gustavsson S. Laparoscopic vs open Rouxen-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001; 11: 284-92.
28. Sjostrom CD, Lissner L, Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477-84.
29. Sjostrom CD, Peltonen M, Wedel H et al. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20-5.
30. Agren G, Narbro K, Naslund I et al. Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes 2002; 26: 184-92.
31. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
32. Long SD, O'Brien K, MacDonald KG Jr et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 1994; 17: 372-5.
33. MacDonald KG Jr, Long SD, Swanson MS et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213-20.
34. Pontiroli AE, Folli F, Paganelli M et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 2005; 28: 2703-9.
35. Hansen EN, Torquati A, Abumrad NN. Results of bariatric surgery. Annu Rev Nutr 2006; 26: 481-511.
36. Pories WJ, Flickinger EG, Meelheim D et al. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Ann Surg 1982; 196: 389-99.
37. Van Rij AM. Gastric bypass and gastric partitioning in morbid obesity: results of a controlled trial. ANZ J Med 1984; 14: 340 (abst).
38. Dolan K, Hatzifotis M, Newbury L et al. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004; 14: 165-9.
39. Thorne A, Lonnqvist F, Apelman J et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes 2002; 26: 193-9.
40. Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002; 6: 1-153.
41. Clegg A, Colquitt J, Sidhu M et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes 2003; 27: 1167-77.
42. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg 2005; 200: 270-8.
43. Narbro K, Agren G, Jonsson E et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes 1999; 23: 619-24.
44. Gallagher SF, Banasiak M, Gonzalvo JP et al. The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. Obes Surg 2003; 13: 245-8.
45. Encinosa WE, Bernard DM, Chen CC et al. Healthcare utilization and outcomes after bariatric surgery. Med Care 2006; 44: 706-12.
46. Martin LF, Tan TL, Horn JR et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995; 118: 599-606; discussion 606-7.
47. van Gemert WG, Adang EM, Kop M et al. A prospective cost-effectiveness analysis of vertical banded gastroplasty for the treatment of morbid obesity. Obes Surg 1999; 9: 484-91.
48. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002; 113: 491-8.
49. Narbro K, Agren G, Jonsson E et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002; 162: 2061-9.
50. Potteiger CE, Paragi PR, Inverso NA et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg 2004; 14: 725-30.
51. Ackroyd R, Mouiel J, Chevallier JM et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg 2006; 16: 1488-503.
52. Pinkney JH, Sjostrom CD, Gale EA. Should surgeons treat diabetes in severely obese people? Lancet 2001; 357: 1357-9.
53. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554-9.
54. Greenway SE, Greenway FL 3rd, and Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137: 1109-17.
55. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes - a systematic review. Diabetes Metab Res Rev 2004; 20: 438-45.
56. Douketis JD, Macie C, Thabane L et al. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes 2005; 29: 1153-67.
57. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462-73.
58. Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459-61.